Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/073840db-c3dd-4551-b9ca-3d23eba6e2db/
THYROCARE
Thyrocare Technologies LimitedSnapshot 2026-07-12 · 0.6w · Fresh
Strategy Eligibility
4 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
3.2%
💰
High Yield
✗
🚀
Momentum Leaders
12-1 47%
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
CAQ 0.72
⚡
Risk-Adj Momentum
RAM 1.04
V
Value Analysis
Cheapness relative to fundamentals
9.0%ile
P/E
50.3×
P/S
10.0×
P/B
14.0×
E/P
0.0249
FCF Yield
0.023
EBITDA/EV
0.033
SH Yield
0.032
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
93.00000000
/100 — 1=cheapest
VC2 (Trending Value)
84.00000000
/100
VC3 (Buyback)
85.00000000
/100
P/E of 50.3x is premium-priced — the market is paying up for expected growth. VC2 score of 84.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
99.0%ile
ROE
0.278
ROA
0.218
Net Margin
0.198
Op Margin
0.249
GPA
0.806
Current
3.39
F-Score
7/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.207
Earn Growth
0.780
Stability
0.378
lower=better
Accruals
-0.067
lower=better
5yr Consist
No
ROE of 28% is exceptional.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
92.0%ile
6M Return
13.3%
12M Return
45.6%
12-1 Mom
47.4%
Risk-Adj
1.04
Vol 252d
45.5%
Vol 60d
102.7%
↑ Expanding
Max DD 12M
-32.6%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 47% is very strong — a clear uptrend. Near-term vol (103%) is expanding vs long-term (46%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.56
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 160 peers
Sector Value %ile
19.3%
Sector Quality %ile
100.0%
P/E z-score
-0.15
P/B z-score
1.70
Sector Avg OS
41.5%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
| Symbol | Name | OS | Value | Quality | Momentum |
|---|---|---|---|---|---|
| LINCOLN | 97.0% | 89.0% | 80.0% | 79.0% | |
| SPARC | 96.0% | 71.0% | 91.0% | 94.0% | |
| NATCOPHARM | 96.0% | 86.0% | 88.0% | 68.0% | |
| VENUSREM | 96.0% | 68.0% | 95.0% | 99.0% | |
| STAR | 95.0% | 75.0% | 91.0% | 84.0% | |
| AUROPHARMA | 95.0% | 73.0% | 83.0% | 90.0% | |
| LUPIN | 94.0% | 64.0% | 98.0% | 86.0% | |
| SAGILITY | 93.0% | 78.0% | 87.0% | 64.0% |
Factor Interactions
Quality Momentum — Expensive
Strong quality (99th) and momentum (92th) but expensive (9th value). Premium priced — watch for mean reversion.
Hot but Volatile
Strong momentum (92th) but high volatility (46%). Momentum could reverse sharply.
Quality at a Premium
High quality (99th) but expensive (9th value). Upside may be limited without earnings growth.
Volatility Expanding
60-day vol (103%) significantly exceeds 252-day (46%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
20.7% avg (7 factors)
Quality
A
90.7% avg (7 factors)
Momentum
B
71.4% avg (4 factors)
Risk
D
40.8% avg (1 factors)
High quality business commanding a premium price. The market recognises the quality — returns from here depend on continued fundamental execution. Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends6 snapshots
Factor Persistence6 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.560 | —0 | — | |
| Value %ile | 0.090 | —6 | — | |
| Quality %ile | 0.990 | —6 | — | |
| Momentum %ile | 0.920 | —6 | — | |
| F-Score | 7.000 | —6 | — | |
| Confidence | 0.920 | —6 | — | |
| Volatility | 0.455 | —6 | — |
Value Lens2021-07-13 → 2026-07-12
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
50.34
Earnings Yield (E/P)
0.0249
Price / Sales
9.99
Price / Book
14.02
Price / Cash Flow
38.49
FCF Yield
2.3%
EBITDA / EV
3.3%
Sales Yield (1/P·S)
0.1000
Shareholder Yield
Div + net buyback / mktcap
3.2%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
27.8%
Return on Assets
21.8%
Net Margin
19.8%
Operating Margin
24.9%
Gross Profit / Assets
Novy-Marx GPA
80.6%
Current Ratio
3.39
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.067
MomentumPrice trend strength over different horizons
6M Return
13.3%
12M Return
45.6%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
47.4%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
1.04
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
20.7%
Earnings Growth (YoY)
78.0%
Earnings Stability (CV)
Lower = more stable
0.378
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
7
Dividend Yield
3.2%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
93
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
84
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
85
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity